Robert C Salisbury's Net Worth

-$50.7 Thousand

Estimate Recalculated Feb 7, 2024 04:00PM EST

Who is Robert C Salisbury?

Robert C Salisbury does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include ENZON PHARMACEUTICALS INC, and VIRAGEN INC.

SEC CIK

Robert C Salisbury's CIK is 0001185468

Past Insider Trading and Trends

2008 was Robert C Salisbury's most active year for acquiring shares with 16 total transactions. Robert C Salisbury's most active month to acquire stocks was the month of June. 2008 was Robert C Salisbury's most active year for disposing of shares, totalling 4 transactions. Robert C Salisbury's most active month to dispose stocks was the month of June. 2004 saw Robert C Salisbury paying a total of $19,250.00 for 350,000 shares, this is the most they've acquired in one year. In 2008 Robert C Salisbury cashed out on 9,562 shares for a total of $13,097.50, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

ENZON PHARMACEUTICALS INC (ENZN) Snapshot price: $0.1

Investor

Robert C Salisbury owns 67,707 units of Common Stock which is worth $6,770.70. From 2005 to 2013 Robert C Salisbury acquired a total of 71,677 shares in ENZON PHARMACEUTICALS INC at a cost of $51,323.98, Robert also disposed a total of 4,030 shares of ENZON PHARMACEUTICALS INC equalling to $13,097.50.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jan 2
Form 4
+18.71%
10.67K
—
—
67.71K
Jul 2
Form 4
—
0
—
—
0
Jan 3
Form 4
+14.87%
7.38K
—
—
57.04K
Jul 1
Form 4
—
0
—
—
0
Jan 3
Form 4
+25.90%
10.22K
—
—
49.66K
Jul 1 - Jul 2
Form 4
—
0
—
—
0
Jan 4
Form 4
+12.17%
4.28K
—
—
39.44K
Jul 2 - Jul 3
Form 4
—
0
—
—
0
Jan 2
Form 4/A
+39.74%
10K
$3.22
$32,210.74
35.16K
Nov 13
Form 4
+7.71%
1.94K
$3.23
$6,015.74
35.16K
Nov 13
Form 4
+173.13%
15.95K
—
—
25.16K
Jul 1 - Jul 3
Form 4
—
0
—
—
0
Jan 2
Form 4
+34.44%
2.36K
—
—
9.21K
Jul 1 - Jul 3
Form 4
—
0
—
—
0
Jan 3
Form 4
+22.42%
1.25K
—
—
6.85K
Jul 1 - Jul 3
Form 4
—
0
—
—
0
Jan 3
Form 4
—
0
—
—
0
Jul 1
Form 3
—
0
—
—
0
Form 4
+179.85%
3.6K
—
—
5.6K
May 12
No matching records found

VIRAGEN INC No price found

President & CEO

Robert C Salisbury owns 205,000 units of Common Stock. From 2004 to 2006 Robert C Salisbury acquired a total of 175,000 shares in VIRAGEN INC at a cost of $19,250.00.

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Apr 7
Form 4
+583.33%
175K
$0.11
$19,250.00
205K
Jan 2
No matching records found